Advertisement

GLP-1s

Independent Blue Cross and Culver City, Calif.-based NantHealth have agreed to provide insurance coverage for a comprehensive whole genome and proteome diagnostic platform to diagnose molecular differences in an individual's cancer and identify personalized therapies.

The U.S. Food and Drug Administration awarded 15 grants, totaling more than $19 million, for the development of medical device, drug and biological products for patients suffering with rare diseases.

Advertisement

Mount Carmel West hospital in Columbus, Ohio, is ending its contract with Consultant Anesthesiology in Columbus and will begin a three-year contract with Alpharetta, Ga.-based Premier Anesthesia Feb. 1, according to a report by The Columbus Dispatch.

Advertisement